Growth hormone treatment

Chairs

Hanneke M. van Santen, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Wassim Chemaitilly, UPMC Children’s Hospital of Pittsburgh, Pennsylvania, United States
Simon Bailey, The Great Northern Hospital, Newcastle, United Kingdom

Coordinator

Jiska van Schaik, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
Laura van Iersel, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands

WG leaders

Laurie Cohen, Montefiore Medical Center, New York, United States
Lillian Meacham, Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
Sogol (Goli) Mostoufi-Moab, The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States

WG members

Christian Denzer, Ulm University Medical Center, Ulm, Germany
Gregory T. Armstrong, St. Jude Children’s Research Hospital, Memphis, United States
Alberto Fernandez, La Paz University Hospital, Madrid, Spain
Cecilie Kiserud, Oslo University Hospital, Oslo, Norway
Roger Packer, School of Medicine and Health Sciences, George Washington University and Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children׳s National Health System, Washington, United States
Briana Patterson, Emory University, Atlanta, United States
Katrin Scheinemann, University of Basel Children’s Hospital, Basel, Switzerland
Netteke Schouten-van Meeteren, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Kumar Srivastava, St. Jude Children’s Research Hospital, Memphis, United States
Michael Walsh, Memorial Sloan Kettering Cancer Center, New York, United States
Angela Delaney, St. Jude Children’s Research Hospital, Memphis, United states
Boudewijn Bakker, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Hoong Wei Gan, Great Ormond Street Hospital for Children, United Kingdom
Lisethe Meijer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Jonathan Wasserman, Sickkids Hospital, Toronto, Canada
Pablo Hernaiz Dreiver,  Charité-Universitätsmedizin Berlin, Germany
Lars Savendahl,  Karolinska University Hospital, Stockholm, Sweden
Zoltan Altan, Memorial Sloan Kettering Westchester, New York, United States
Jennifer Abuzzahab, Children’s Hospitals and Clinics of Minnesota, St Paul, Minnesota, United States
Ulrich Paetow, Klinik für Kinder- und Jugendmedizin, Frankfurt am Main, Germany
Nathalie Alos, Research Center, Sainte-Justine Hospital Center, Montreal, Canada
Maya Lodish, Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States
Maura Massimino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Peter Clayton, GOS Institute of Child Health, London, United Kingdom
Anita Hokken, Erasmus Medical Center, Rotterdam, The Netherlands
Gerhard Binder, Children’s Hospital, University of Tübingen, Germany
Stephanie Smetsers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Gudmundur Johannsson, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Margaret Boguszewski, Federal University of Parana, Curitiba, Brazil